Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Disturbances in Heart Rhythm
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 18, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
1Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
No abstract available in PubMed .